Washington [US], March 21 (ANI): Patients with low vitamin D levels who are hospitalised for COVID-19 may have a lower risk of dying or requiring mechanical ventilation if they receive vitamin D supplementation of at least 1,000 units weekly, according to a study presented virtually at the E
Washington [US], March 2 (ANI): A recent study has found that a series of biomarkers, or biological signals, associated with white blood cell activation and obesity can predict severe outcomes in COVID-19 patients.
Washington [US], February 27 (ANI): A research led by a team of scientists at the University of Exeter claimed that progressive exercise and early mobilisation are the most important elements of rehabilitation programs that may improve recovery for people who are hospitalised with severe COV
Washington [US], February 24 (ANI): Progressive exercise and early mobilisation are among the elements of rehabilitation programs that may improve recovery for people who are hospitalised with severe COVID-19, new research has concluded.
Washington [US], February 21 (ANI): A recent study revealed that approximately 50 per cent of patients, who are hospitalized due to severe COVID-19 symptoms, show raised levels of a protein called troponin that causes damage to their hearts.
Washington [US], February 20 (ANI): Through a clinical study published in the European Heart Journal, scientists claim that around half of the patients studied have had their heart damaged subsequent to being hospitalised with severe COVID-19 and they showed elevated levels of a protein call
Washington [US], February 18 (ANI): Around 50 per cent of patients who have been hospitalised with severe COVID-19 and who show raised levels of a protein called troponin cause damage to their hearts.
Washington [US], February 17 (ANI): A new study has suggested that a genetic variant associated with reduced coronavirus severity was inherited from Neandertals.
Washington [US], February 10 (ANI): The US Food and Drug Administration (FDA) has granted an emergency use authorization to a monoclonal antibody cocktail made by pharmaceutical company Eli Lilly for treating coronavirus patients at high risk of developing severe COVID-19.
Washington [US], January 25 (ANI): A new study found that patients with inactive cancer and not currently undergoing treatments for the deadly disease also face a significantly higher risk of severe illness from COVID-19.
Washington [US], January 12 (ANI): People infected with COVID-19 experience a wide range of symptoms and severities, the most commonly reported including high fevers and respiratory problems, suggest the findings of a new review.
Washington [US], December 27 (ANI): Coronavirus antibodies wane significantly within several months of infection and preferentially target a different part of the virus in mild cases than in comparison to severe ones, suggest the findings of a new study.